Treatment with elexacaftor-tezacaftor-ivacaftor is associated with reduced levels of systemic inflammatory markers, which ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s ...
Dr. Drucy Borowitz helped turn cystic fibrosis from a deadly childhood illness into a treatable condition, giving families ...
Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.
TipRanks on MSN
Vertex and Moderna’s VX-522 Study: A Potential Breakthrough in Cystic Fibrosis Treatment
This study update could positively impact Vertex Pharmaceuticals and Moderna’s stock performance, as successful results may enhance their competitive position in the cystic fibrosis treatment market.
Arcturus Therapeutics (($ARCT)) announced an update on their ongoing clinical study. Study Overview: Arcturus Therapeutics is conducting a Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback